- Home
- COYA vs BHST Comparison
COYA vs BHST Comparison
Compare COYA & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COYA
- BHST
- Stock Information
- Founded
- COYA 2020
- BHST 2007
- Country
- COYA United States
- BHST Canada
- Employees
- COYA N/A
- BHST N/A
- Industry
- COYA Biotechnology: Pharmaceutical Preparations
- BHST
- Sector
- COYA Health Care
- BHST
- Exchange
- COYA Nasdaq
- BHST Nasdaq
- Market Cap
- COYA 103.2M
- BHST 106.0M
- IPO Year
- COYA 2022
- BHST N/A
- Fundamental
- Price
- COYA $5.93
- BHST $6.50
- Analyst Decision
- COYA Strong Buy
- BHST Strong Buy
- Analyst Count
- COYA 4
- BHST 2
- Target Price
- COYA $17.00
- BHST $13.00
- AVG Volume (30 Days)
- COYA 66.8K
- BHST 26.8K
- Earning Date
- COYA 05-13-2025
- BHST 05-15-2025
- Dividend Yield
- COYA N/A
- BHST N/A
- EPS Growth
- COYA N/A
- BHST N/A
- EPS
- COYA N/A
- BHST N/A
- Revenue
- COYA $3,685,107.00
- BHST $27,704,000.00
- Revenue This Year
- COYA $94.45
- BHST $116.40
- Revenue Next Year
- COYA N/A
- BHST $55.91
- P/E Ratio
- COYA N/A
- BHST N/A
- Revenue Growth
- COYA N/A
- BHST 74.76
- 52 Week Low
- COYA $4.65
- BHST $0.00
- 52 Week High
- COYA $10.24
- BHST $7.38
- Technical
- Relative Strength Index (RSI)
- COYA 48.29
- BHST N/A
- Support Level
- COYA $5.63
- BHST N/A
- Resistance Level
- COYA $6.53
- BHST N/A
- Average True Range (ATR)
- COYA 0.46
- BHST 0.00
- MACD
- COYA -0.03
- BHST 0.00
- Stochastic Oscillator
- COYA 29.70
- BHST 0.00
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
About BHST BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.